Accessibility Menu
 
Abrdn Life Sciences Investors logo

Abrdn Life Sciences Investors

(NYSE) HQL

Current Price$16.27
Market Cap$459.36M
Since IPO (1992)+1,775%
5 Year+38%
1 Year+40%
1 Month-4%

Abrdn Life Sciences Investors Financials at a Glance

Market Cap

$459.36M

Revenue (TTM)

$33.81M

Net Income (TTM)

$170.89M

EPS (TTM)

$2.89

P/E Ratio

5.50

Dividend

$1.91

Beta (Volatility)

0.74 (Low)

Price

$16.27

Volume

299,461

Open

$16.03

Previous Close

$16.27

Daily Range

$15.98 - $16.52

52-Week Range

$10.55 - $17.80

HQL News

HQL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Abrdn Life Sciences Investors

Industry

Capital Markets

Headquarters

Philadelphia, MA 02110, US

HQL Financials

Key Financial Metrics (TTM)

Gross Margin

31%

Operating Margin

3%

Net Income Margin

3%

Return on Equity

18%

Return on Capital

17%

Return on Assets

17%

Earnings Yield

18.18%

Dividend Yield

0.12%

Payout Ratio

36.96%

Stock Overview

Market Cap

$459.36M

Shares Outstanding

28.87M

Volume

299.46K

Short Interest

0.00%

Avg. Volume

124.48K

Financials (TTM)

Gross Profit

$86.39M

Operating Income

$85.59M

EBITDA

$85.59M

Operating Cash Flow

$2.32M

Capital Expenditure

$5.00

Free Cash Flow

$2.32M

Cash & ST Invst.

$75.54K

Total Debt

$0.00

Abrdn Life Sciences Investors Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$11.63M

-60.6%

Gross Profit

$9.19M

-65.9%

Gross Margin

78.99%

N/A

Market Cap

$459.36M

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$132.83M

+1260.0%

EBITDA

$132.83M

+1260.3%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$75.54K

-99.5%

Accounts Receivable

$1.14M

-77.4%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

16.61%

N/A

Return on Invested Capital

16.63%

N/A

Free Cash Flow

$1.28M

N/A

Operating Cash Flow

$1.28M

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CCAPCrescent Capital BDC, Inc.
$12.15-2.10%
ECCEagle Point Credit Company Inc.
$3.76+4.16%
GLADGladstone Capital Corporation
$17.35+1.05%
SORSource Capital, Inc.
$46.41+4.07%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$41.68+0.10%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.55-0.11%
APLSApellis Pharmaceuticals
$40.23+1.35%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$80.49-0.10%

Questions About HQL

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.